Fundz

Who to call at Aurinia Pharmaceuticals, and when

Fundz watches for the moments Aurinia Pharmaceuticals starts buying, and tells you who to reach.

  • An alert the day Aurinia Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Aurinia Pharmaceuticals, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Aurinia Pharmaceuticals and Teva Settle Patent Infringement Litigation

Aug 19, 2026

Contract Type

settlement_agreement

BiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharma

Description

On August 19, 2026, Aurinia Pharmaceuticals Inc. announced a settlement agreement with Teva Pharmaceuticals Inc. to resolve patent infringement litigation. This litigation was related to Teva's filing of an Abbreviated New Drug Application for generic voclosporin oral capsules

Company Information

Company

Aurinia Pharmaceuticals

About

Aurinia Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of kidney diseases. Their lead product, LUPKYNIS® (voclosporin), is specifically designed to treat lupus nephritis. Aurinia is committed to advancing scientific understanding and improving patient outcomes in nephrology. The company's mission emphasizes addressing unmet medical needs in patients with rare diseases.

Predictive Intelligence
Strategic

ML-powered predictions for Aurinia Pharmaceuticals's next move

Learn about Strategic plan

Aurinia Pharmaceuticals signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.